Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jan 19, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the way we manage adrenal diseases, such as adrenal tumors, primary aldosteronism, Cushing syndrome, and pheochromocytoma. Researchers are collecting real-world information from patients at two hospitals in South Korea to create better treatment guidelines. By building a registry of patients, they aim to gather data that will help them understand these conditions better and develop effective treatment plans.
If you are at least 19 years old and have any of the specified adrenal conditions, you may be eligible to participate in this study. Participants will have the opportunity to contribute to important research that could lead to improved care for individuals with adrenal diseases. It’s a chance to help shape future treatment strategies while receiving support from healthcare professionals throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with adrenal diseases such as adrenal cortical carcinoma, Cushing's syndrome, primary aldosteronism, pheochromocytoma, adrenal incidentaloma
- • patients who are 19 years or older
- Exclusion Criteria:
- • patients younger than 19 years old
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, Gwanak Gu, Korea, Republic Of
Patients applied
Trial Officials
Jung Hee Kim, MD, PhD
Principal Investigator
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported